+41 91 682 20 40 info@elixi-int.com

Merck & Co. has started the marketing in Germany of Prevymis (Letermovir), a therapy against Cytomegalovirus infections (CMV) developed by the German biotech Aicuris

Prevymis is an antiviral medicine used to prevent illness caused by cytomegalovirus (CMV) in adults having an allogeneic haematopoietic stem cell transplant to replace their bone marrow. Allogeneic haematopoietic stem cell transplantation involves using stem cells from a donor to…

Read More